Pharmaceuticals in Belgium

Pharmaceuticals in Belgium


November 21, 2012
35 Pages - SKU: MTLN4921108
License type:
Online Download      US $350.00
Global Site License      US $875.00
Countries covered: Belgium

Introduction

Pharmaceuticals in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Belgium pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The Belgian pharmaceuticals market had total revenues of $6.2 billion in 2011, representing a compound annual growth rate (CAGR) of 3.2% between 2007 and 2011.
  • The performance of the market is forecast to decelerate, with an anticipated CAGR of 1% for the five-year period 2011 - 2016, which is expected to drive the market to a value of $6.5 billion by the end of 2016.
Features

Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Belgium

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Belgium

Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Belgium pharmaceuticals market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Belgium economy

Key Questions Answered

What was the size of the Belgium pharmaceuticals market by value in 2011?

What will be the size of the Belgium pharmaceuticals market in 2016?

What factors are affecting the strength of competition in the Belgium pharmaceuticals market?

How has the market performed over the last five years?



More Country Overviews reports by MarketLine

Pharmaceuticals in Asia-Pacific by MarketLine
IntroductionPharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). The profile also contains ...
Pharmaceuticals: Global Industry Guide by MarketLine
Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals: Global Industry Guide industry. It includes detailed data on ...
Pharmaceuticals: Global Industry Almanac by MarketLine
Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and ...
Pharmaceuticals - North America (NAFTA) Industry Guide by MarketLine
Pharmaceuticals - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the North ...
See all reports like this >>

More Belgium Country Overviews reports

Belgium Pharmaceuticals and Healthcare Report Q2 2014 by Business Monitor International
Belgium Pharmaceuticals and Healthcare Report Q2 2014BMI View: Belgium continues along the path of recovery. It is a European hub for clinical trials, new drugdevelopment ...
Belgium Pharmaceuticals and Healthcare Report Q2 2013 by Business Monitor International
BMI View: Our forecast sees the Belgian pharmaceutical market contracting over the next three years,only returning to year-on-year (y-o-y) growth in 2015. We have based ...
Belgium Pharmaceuticals and Healthcare Report Q3 2012 by Business Monitor International
BMI View: Belgium’s rapidly ageing population, traditionally high per capita consumption of medicines and a well-developed healthcare system will combine to continue providing substantial commercial ...
The Pharmaceutical Market: Belgium by Espicom Healthcare Intelligence
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of ...
See all reports like this >>

More Belgium reports

D&B Country RiskLine Report: Belgium by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
See all reports like this >>